Aldeyra Therapeutics Inc. Insider Trading
ALDX
3 insiders bought 140K of their own stock in 2 days.
Open-market purchases by executives and directors between Nov 11 and Nov 12. Buying is rarer than selling and says more, but it is one input, not a verdict.
Get an email when ALDX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12 | Darlene M Deptula-Hicks Director | Bought | 7,500 | $0.65 | 5K | New | Form 4 |
| Nov 11 | Michael Alfieri Principal Financial Officer | Bought | 10,000 | $0.65 | 7K | 133% | Form 4 |
| Nov 11 | Richard Douglas Director | Bought | 200,000 | $0.64 | 129K | 103% | Form 4 |
| Jun 3 | Todd C Brady President and CEO | Bought | 250,000 | $1.67 | 418K | 17% | Form 4 |
| Mar 19 | Richard Douglas Director | Bought | 70,000 | $1.40 | 98K | 56% | Form 4 |
| Mar 18 | Michael Alfieri Principal Financial Officer | Bought | 5,000 | $1.42 | 7K | 200% | Form 4 |
| Aug 13, 2025 | Michael Alfieri Principal Financial Officer | Bought | 2,500 | $5.30 | 13K | New | Form 4 |
| Aug 11, 2025 | Stephen Machatha Chief Development Officer | SoldNo plan | 22,073 | $5.15 | 114K | 9.1% | Form 4 |
| Apr 3, 2025 | Perceptive Life Sciences Master Fund LTD Large holder | SoldNo plan | 3,400,000 | $1.42 | $4.83M | 37% | Form 4 |
- Nov 12Darlene M Deptula-HicksDirector · bought 7,500 at $0.655KNew position
- Nov 11Michael AlfieriPrincipal Financial Officer · bought 10,000 at $0.657K133% of stake
- Nov 11Richard DouglasDirector · bought 200,000 at $0.64129K103% of stake
- Jun 3Todd C BradyPresident and CEO · bought 250,000 at $1.67418K17% of stake
- Mar 19Richard DouglasDirector · bought 70,000 at $1.4098K56% of stake
- Mar 18Michael AlfieriPrincipal Financial Officer · bought 5,000 at $1.427K200% of stake
- Aug 13, 2025Michael AlfieriPrincipal Financial Officer · bought 2,500 at $5.3013KNew position
- Aug 11, 2025No planStephen MachathaChief Development Officer · sold 22,073 at $5.15114K9.1% of stake
- Apr 3, 2025No planPerceptive Life Sciences Master Fund LTDLarge holder · sold 3,400,000 at $1.42$4.83M37% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ALDX
Held by ETFs
ALDX is in 2 US ETFs. The largest of them, with ALDX's weight in each:
Spot a number that looks wrong? Check it in ALDX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ALDX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.